Detalles de la búsqueda
1.
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases.
Pharmacoepidemiol Drug Saf
; 29(8): 951-957, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399991
2.
Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions.
Pharmacoepidemiol Drug Saf
; 28(3): 389-395, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30556617
3.
Benefit-risk assessment of vaccines.
Vaccine
; 42(4): 969-971, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563049
4.
Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally.
Vaccine X
; 18: 100485, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38655548
5.
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group.
BMJ Glob Health
; 9(3)2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453518
6.
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Vaccine
; 41(25): 3790-3795, 2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198019
7.
Considerations for unblinding individual study participants during vaccine trials.
Vaccine
; 41(22): 3399-3402, 2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37121805
8.
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.
Pharmaceut Med
; 36(3): 153-161, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486326
9.
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.
Drug Saf
; 44(6): 681-697, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837924
10.
Consensus clustering for case series identification and adverse event profiles in pharmacovigilance.
Artif Intell Med
; 122: 102199, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823833
11.
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine
; 39(22): 3037-3049, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33640145
12.
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.
Drug Saf
; 43(11): 1121-1131, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32617874
13.
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX vaccine safety working group
BMJ Glob Health, v. 9, n. 3, e014544, jan. 2024
Artículo
en Inglés
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-5276
14.
Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
Am J Trop Med Hyg
; 98(2): 382-388, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29210346
15.
Case reports as early safety signals: learning from the COVID-19 vaccination campaign.
Front Med (Lausanne)
; 10: 1348376, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264054
16.
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Drug Saf
; 41(2): 203-212, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933055
17.
Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors.
Infect Control Hosp Epidemiol
; 28(2): 116-22, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17265391
18.
The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities.
Drug Saf
; 45(6): 597-599, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35532845
19.
Correction to: Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
Drug Saf
; 40(12): 1295, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080142
20.
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®.
Drug Saf
; 40(1): 81-90, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27638661